A citation-based method for searching scientific literature

Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
Times Cited: 64



Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm, Lilian Wikström. J Neurosci Res 2008
Times Cited: 244




List of shared articles



Times cited

Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging.
Grazyna Lietzau, Giulia Magni, Jan Kehr, Takashi Yoshitake, Emanuel Candeias, Ana I Duarte, Hans Pettersson, Josefin Skogsberg, Maria P Abbracchio, Thomas Klein,[...]. Neurobiol Aging 2020
8

Old wines in new bottles: Repurposing opportunities for Parkinson's disease.
Ashish Kumar Kakkar, Harmanjit Singh, Bikash Medhi. Eur J Pharmacol 2018
12


Neuromodulatory effects of anti-diabetes medications: A mechanistic review.
Habib Yaribeygi, Milad Ashrafizadeh, Neil C Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar. Pharmacol Res 2020
19

Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson's Disease.
Yilin Tang, Ke Yang, Jue Zhao, Xiaoniu Liang, Jian Wang. ACS Chem Neurosci 2019
2

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
5

Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
23

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
41

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease-Viewpoint.
Carolina Sportelli, Daniele Urso, Peter Jenner, K Ray Chaudhuri. Front Neurol 2020
10